You are here
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
SBC: BIOSCALE, INC. Topic: CBD03201
Having achieved or exceeded all goals and objectives of the Phase I research program, BioScale has thus demonstrated feasibility of a multiplexed, immuno-electromechanical pathogen detection method. In Phase II, BioScale proposes to advance this research by assembling a complete assay system that integrates discrete, commercial off the shelf (COTS) sample preparation subcomponents with the propri ...SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense
SBC: ALPHA-GAMMA TECHNOLOGIES, INC. Topic: CBD04113
DNA microarray technology, in combination with statistical and predictive modeling tools, could be used to evaluate thousands of genes against distinct gene expression patterns induced by chemical/biological agents to provide early identification and speed therapeutic intervention. The overall objective of this Phase II effort is to leverage existing public domain resources and commercial tools t ...SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense
SBC: SIGMA K CORP Topic: CBD04110
Effective collective protection fabrics must have a reliable closure system. During our Phase I Work Plan, Sigma-K began developing a Hermetic Textile Closure Hardware (HATCH) system. The HATCH combines both a magnetic and geometric self locking mechanism that will provide a hermetic seal when closed. Our current Phase I successes include developing self closing samples that can provide a hermetic ...SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense